AngioDynamics Inc at UBS Global Healthcare Conference (Virtual) Transcript
Thanks. Good morning. Thanks for joining us. I'm Matt Taylor, UBS's U.S. medical supplies and devices analyst, and we're really pleased to be joined by management from AngioDynamics. We have on the line with us Jim Clemmer, who's the President and CEO of the company.
And AngioDynamics is a diversified med tech company that has businesses that cross a number of different areas involved with both critical care and elective care that we'll get into later in the program here, including devices for vascular access, oncology treatment, vascular interventions. And they've been very active in business development to move into some areas that are higher growth and higher margin over the last couple of years.
So Jim, thanks a lot for joining us today, and I'm excited to dive into some topics on Angio with you.
So thanks, Matt, for the invitation to the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
